Cannabis finance news

Althea resumes trading on ASX as board narrowly avoids a second shareholder revolt

by Steve Jones February 3, 2025February 3, 2025

Althea has resumed trading on the Australian Securities Exchange (ASX) while narrowly avoiding a destabilising shareholder […]

Cannabinoid Oil In Laboratory - Medical Cannabis Australia - Cannabiz

Gibraltar company snaps up Bod Science low-dose CBD clinical research data

by Steve Jones January 30, 2025January 30, 2025

Financial results: Rua Bioscience

by Martin Lane January 29, 2025January 29, 2025

ECS Botanics sales fall amid shift to consumer strategy

by Steve Jones January 29, 2025January 29, 2025

Althea set for court this week after detecting 14 breaches of ASX rules

by Steve Jones January 28, 2025January 28, 2025

Bioxyne upgrades revenue forecast on back of record Q2

by Martin Lane January 24, 2025January 29, 2025

Montu pays out $6.3m to minority shareholders as buy-back scheme concludes

by Steve Jones January 23, 2025January 23, 2025

Melodiol Global Health creditors vote to wind up company

by Steve Jones January 23, 2025January 23, 2025

Deal for OneLife Wonthaggi facility expected to be finalised next month

by Steve Jones January 23, 2025January 23, 2025

Directors ‘may have breached duties’, report alleges, as Melodiol Global Health heads for liquidation

by Steve Jones January 15, 2025January 16, 2025